Teaching an old dog new tricks: potential antiatherothrombotic use for statins

Area of Science:

• Cardiovascular Medicine
• Atherosclerosis Research
• Thrombosis and Hemostasis

Background:

• Hypercholesterolemia and atherosclerosis are major contributors to cardiovascular morbidity and mortality.
• A prothrombotic and proinflammatory state is characteristic of these conditions.
• Understanding the underlying mechanisms is crucial for developing effective antiatherothrombotic therapies.

Purpose of the Study:

• To investigate the mechanisms driving the prothrombotic and proinflammatory state associated with hypercholesterolemia.
• To explore the role of circulating oxidized low-density lipoprotein (LDL) and monocyte-derived tissue factor.
• To evaluate the effect of statin therapy on this phenotype, independent of cholesterol levels.

Main Methods:

• Studies were conducted using rodent, monkey, and human subjects.
• Analysis focused on circulating oxidized LDL levels and monocyte-derived tissue factor expression.
• The impact of statin therapy on the prothrombotic and inflammatory phenotype was assessed.

Main Results:

• Circulating oxidized LDL and monocyte-derived tissue factor were identified as key instigators of the thrombotic and inflammatory phenotype.
• Statin therapy significantly ameliorated this phenotype, even when cholesterol levels were not reduced.
• These findings suggest a cholesterol-independent effect of statins on atherothrombosis.

Conclusions:

• Targeting pathways generating oxidant stress or mediating oxidized LDL signals in platelets and monocytes may offer novel antiatherothrombotic strategies.
• Such therapies could potentially provide benefits with minimal anticoagulant or hemorrhagic risks.
• This research opens new avenues for treating hypercholesterolemia-associated thrombotic complications.